VarmX raises €30M Series B2 financing for IND approval and preparations for pivotal trial
The proceeds from the financing will enable VarmX to obtain investigational new drug (IND) approval for its lead compound VMX-C001 and to complete preparations for the pivotal clinical trial, including large scale manufacturing.
Published on
01/06/2023
Read time
1m